Nicko displays the device, a Philips DreamStation, to the camera, noting that it has “now been recalled.” He claims this is because the sound-abating foam inside breaks down, “and then it travels into ...

The global respiratory diagnostics market, valued at US$ 5.85 billion in 2023, is forecasted to grow at a robust CAGR of 6.5%, reaching US$ ...

A group of over hundred institutional investors are claiming over 800 million euros worth of damages from Philips. The ...

Sleep Apnea Therapy System Market. Key market drivers for Sleep Apnea Therapy System Market include rising prevalence of sleep apnea disorders, growing awa ...

Koninklijke Philips NV (ETR:PHI1 ... forecast also includes an expected margin improvement and a recovery of the Respironics business. These factors are projected to contribute to a compound ...

Starting with positive news, the CEO communicated a return to cash dividends, as Philips’ balance sheet is in good shape (even considering the settling for $1.1 billion). Additionally ...

I’m sure many other biotechs are active in the field. Due to the ongoing problems at Philips Respironics, RMD continues to benefit from the absence of a key competitor in the US OSA/respiratory ...

This innovation aims to enhance patient comfort and improve treatment outcomes. In December 2023 , Philips announced the release of its DreamStation 2, a next-generation CPAP machine that offers ...

Magnets in continuous positive airway pressure (CPAP) masks led to Class I recalls in recent years for Philips Respironics and ResMed. Brushless DC motors are a promising alternative to traditionally ...

manufactured by Philips Respironics Company), respectively. The off-line BCG-based signal processing was then undertaken, including artifact and signal quality (SQ) labeling, heartbeat interval ...

Philips sleep apnea machines, which have been recalled and linked to 500 deaths, are now the subject of a $400 million plus ...